Dr Reddys Laboratories (RDY) Notes Payables (2017 - 2025)
Historic Notes Payables for Dr Reddys Laboratories (RDY) over the last 10 years, with Q1 2025 value amounting to $439.3 million.
- Dr Reddys Laboratories' Notes Payables rose 18677.0% to $439.3 million in Q1 2025 from the same period last year, while for Mar 2025 it was $439.3 million, marking a year-over-year increase of 18677.0%. This contributed to the annual value of $445.0 million for FY2025, which is 19084.97% up from last year.
- Per Dr Reddys Laboratories' latest filing, its Notes Payables stood at $439.3 million for Q1 2025, which was up 18677.0% from $537273.4 recorded in Q3 2024.
- In the past 5 years, Dr Reddys Laboratories' Notes Payables ranged from a high of $439.3 million in Q1 2025 and a low of $37628.3 during Q3 2022
- Over the past 5 years, Dr Reddys Laboratories' median Notes Payables value was $121.6 million (recorded in 2023), while the average stood at $170.1 million.
- In the last 5 years, Dr Reddys Laboratories' Notes Payables tumbled by 7503.97% in 2023 and then surged by 101034.56% in 2024.
- Dr Reddys Laboratories' Notes Payables (Quarter) stood at $317.3 million in 2021, then crashed by 99.99% to $37628.3 in 2022, then increased by 28.59% to $48387.9 in 2023, then skyrocketed by 1010.35% to $537273.4 in 2024, then soared by 81673.07% to $439.3 million in 2025.
- Its Notes Payables was $439.3 million in Q1 2025, compared to $537273.4 in Q3 2024 and $153.2 million in Q1 2024.